Press release
Filgrastim Biosimilars Market 2023: Global Industry Growth Factors, Trends, Demand Status And Forecast To 2032
Filgrastim Biosimilars Market
As per the filgrastim biosimilars market report by The Business Research Company, Government initiatives for the development of biosimilars are expected to drive the filgrastim biosimilars market over the coming years. Governments worldwide are focusing on the development of biosimilars due to their cost-effective nature. The US Food and Drug Administration (FDA) launched a Biosimilar Action Plan, to increase treatment options.
The global filgrastim biosimilars market grew from $0.88 billion in 2022 to $0.95 billion in 2023 at a compound annual growth rate (CAGR) of 8.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The filgrastim biosimilars market is expected to grow from $1.33 billion in 2027 at a CAGR of 8.9%.
Read More On The Filgrastim Biosimilars Market Report Here:
https://www.thebusinessresearchcompany.com/report/filgrastim-biosimilar-global-market-report
Major competitors in the filgrastim biosimilars market include Cadila Pharmaceuticals, Dr. Reddy's Laboratories, Intas Biopharmaceuticals, Sandoz, Amgen Inc., Dr. Reddy's Laboratories Ltd., Intas Pharmaceuticals, Emcure Pharmaceuticals Ltd., Biocon, and Aryogen Biopharma
The filgrastim biosimilars market is segmented -
By Application: Oncology, Chronic And Autoimmune Diseases, Blood Disorders, Growth Hormone Deficiency, Infectious Diseases, Other Applications
Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
By Type Of Manufacturing: In-House Manufacturing, Contract Manufacturing Organizations
By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the filgrastim biosimilars market.
Check Out Buying Options For The Filgrastim Biosimilars Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=4016
Filgrastim biosimilars refer to a biosimilar that is intended to treat patients who suffer bone marrow damage from extremely high radiation doses in a manner similar to how it helps cancer patients by stimulating the formation of white blood cells, making patients less susceptible to infections.
The Table Of Content For The Filgrastim biosimilars market Include:
1. Executive Summary
2. Filgrastim Biosimilars Market Characteristics
3. Filgrastim Biosimilars Market Trends And Strategies
4. Filgrastim Biosimilars Market - Macro Economic Scenario
5. Filgrastim Biosimilars Market Size And Growth
........
27. Filgrastim Biosimilars Market Competitive Landscape And Company Profiles
28. Filgrastim Biosimilars Pipeline Analysis
29. Key Mergers And Acquisitions In The Filgrastim Biosimilars Market
30. Filgrastim Biosimilars Market Future Outlook and Potential Analysis
31. Appendix
The "Global Filgrastim biosimilars market Report 2023" from The Business Research Company is a comprehensive report that covers every facet of a market covering over 60 geographies and over 2500 market segments. The regional and country breakdowns section analyzes the market in each geography and the market size by region and country. Furthermore, it assesses the market's historical and projected growth and identifies significant trends and strategies that companies can leverage for business expansion.
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Filgrastim Biosimilars Market 2023: Global Industry Growth Factors, Trends, Demand Status And Forecast To 2032 here
News-ID: 2872101 • Views: 255
More Releases from The Business research company
Argon Market Analysis: Promising Segments and Share Projections || Airgas, Air L …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
The Business Research Company's Argon Global Market Report 2023 identifies the growing demand from the electronics industry is the major driver for the argon market's growth in the forecast period. As argon gas provides an inert atmosphere needed for rapid cooling and heating of materials, it will…
Nanotechnology-Based Medical Devices Global Market is Expected to Grow $9.07 Bil …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
The Business Research Company's Nanotechnology-Based Medical Devices Global Market Report 2023 identifies the increasing prevalence of chronic diseases is expected to propel the growth of the nanotechnology-based medical device market going forward. Chronic diseases are defined as problems that last for a year or longer and necessitate…
Instrument Landing System And Visual Landing Aids Global Market $2.74 Billion By …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
The Business Research Company's Instrument Landing System And Visual Landing Aids Global Market Report 2023 identifies the increasing air traffic is expected to propel the growth of the instrument landing system, and virtual landing aids market going forward. Air traffic refers to the number of aircraft flying…
High Density Interconnect Global Market Worth $22.36 Billion at a CAGR of 10.4% …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
The Business Research Company's High Density Interconnect Global Market Report 2023 identifies The increasing application of the automotive industry is expected to propel the growth of the high-density interconnect market going forward. The automotive industry is a sector that encompasses numerous organizations and firms involved in the…
More Releases for Filgrastim
Filgrastim Biosimilar Insight report on 20+ companies and 20+ marketed and pipel …
(Albany, US) Filgrastim Biosimilar Insight report on 20+ companies and 20+ marketed and pipeline drugs | DelveInsight
"Filgrastim Biosimilar Insight, 2022" by DelveInsight covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products with Global coverage. It also includes the therapeutics assessment by product type, stage, route of administration, and molecule type. It further showcases the inactive pipeline products in this space.
Filgrastim Biosimilar Report Highlights
• The companies and…
Filgrastim Biosimilars Market 2022-2031 | Industry Overview, Estimated Growth, C …
Filgrastim Biosimilars Global Market Report 2022 - Market Size, Trends, And Global Forecast 2022-2026 by The Business Research Company is the most comprehensive report available on this market, with analysis of the market's historic and forecast growth, drivers and restraints causing it, and highlights of the opportunities that companies in the industry can take on. The filgrastim biosimilars market research report helps gain a truly global perspective of the filgrastim…
Filgrastim Biosimilars Market Forecast 2021-2030 | Key Markets and Segment Perfo …
Get up to 33% off on ALL market research reports at The Business Research Company's holiday sale; buy now!
https://www.thebusinessresearchcompany.com/global-market-reports
‘Filgrastim Biosimilars Global Market Report 2021 – COVID-19 Growth And Change’ by The Business Research Company is the most comprehensive report available on this market, with analysis of the market’s historic and forecast growth, drivers and restraints causing this, and highlights of the opportunities that companies in the industry can take…
Filgrastim Market Strategic Assessment, Growth Analysis and Research Outlook 202 …
Latest research on Filgrastim Market report covers forecast and analysis on a worldwide, regional and country level. The study provides historical information of 2015-2021 together with a forecast from 2021 to 2027 supported by both volume and revenue (USD million). The entire study covers the key drivers and restraints for the Filgrastim market. This report included a special section on the Impact of COVID19. Also, Filgrastim Market (By major Key…
Filgrastim Biosimilars Market Segmentation, Regional Analysis And Growth: Biocon …
The global filgrastim biosimilars market reached a value of nearly $785.33 million in 2019, having increased at a compound annual growth rate (CAGR) of 12.13% since 2015. The market is expected to grow from $785.33 million in 2019 to $860.12 million in 2023 at a rate of 2.30%. The market is expected to grow from $860.12 million in 2023 to $984.23 million in 2025 at a CAGR of 6.97%.…
Filgrastim Market Professional Analysis Report 2019| Amgen, SANDOZ INC, Teva
The report on the global Filgrastim market is comprehensively prepared with main focus on the competitive landscape, geographical growth, segmentation, and market dynamics, including drivers, restraints, and opportunities. It sheds light on key production, revenue, and consumption trends so that players could improve their sales and growth in the Global Filgrastim Market. It offers a detailed analysis of the competition and leading companies of the global Filgrastim market. Here, it…
